Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacific Biosciences develops and commercializes advanced DNA/RNA sequencing platforms used globally in genomics research. Its SMRT and HiFi technologies are recognized for high accuracy and long read lengths. The company’s products are widely adopted in academic, clinical, agricultural, infectious disease, oncology, and population genomics projects. PacBio does not conduct clinical trials as a therapeutic developer but its technologies have enabled landmark studies such as the Telomere-to-Telomere human genome project and large-scale population genomics initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacific Biosciences.